Birmingham, West Midlands -- (SBWIRE) -- 01/23/2014 -- Value Penny Stocks issues special report on Angie's List Inc (NASDAQ:ANGI), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Infinera Corp. (NASDAQ:INFN), Arca Biopharma Inc (NASDAQ:ABIO).
Angie's List Inc (NASDAQ:ANGI) ended its recent business day with the gain of 3.45% and closed at the price of $16.20 after opening at $15.60. The stock traded during its last trading session with the total volume of 1,978,481 shares, as compared to its average volume of 1.27 million shares. Angie’s List, Inc. operates a consumer-driven solution for its members to research, hire, rate, and review local professionals for home, health care, and automotive service needs. It offers member services comprising member-generated ratings and reviews that provide reviews from both members and non-members in 550 categories.
Will ANGI Continue To Move Higher? Find Out Here
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) remained among the day decliners and traded with volume of 1,956,140 shares in the last session, as compared to average volume of 1.11 million shares. In comparison with 52 week range of $8.95 - $19.67, it faced lowest price of $14.09 during the last trading session whereas its day highest price was $15.05. The company’s total market capitalization is $1.75 billion, along with 120.93 million shares outstanding. Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products.
Has IRWD Found The Bottom And Ready To Gain Momentum? Find Out Here
Infinera Corp. (NASDAQ:INFN) showed 1,947,331 shares in volume during the last trading session, while the average trading volume remained 1.74 million shares. The stock kicked off its trading session at $7.54 and closed at $7.62 after mounting 0.79%. Infinera Corporation provides optical networking equipment, software, and services to communications service providers, Internet content providers, cable operators, and subsea network operators worldwide.
For How Long INFN will Fight for Profitability? Read This Trend Analysis report
Arca Biopharma Inc (NASDAQ:ABIO) stock traded during its last trading session with the total traded volume of 1,953,216 shares versus its average volume of 1.46 million shares. The company opened its trade at the price of $2.12 and its closing price was $2.16 after gaining 1.89% for the day. ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction.
Why Should Investors Buy ABIO After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)